These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 15911797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS.
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
    Bao SY, Wu JC, Luo WF, Fang P, Liu ZL, Tang J.
    J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD.
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [Abstract] [Full Text] [Related]

  • 10. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR.
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.
    Bor-Seng-Shu E, Felicio AC, Braga-Neto P, Batista IR, Paiva WS, de Andrade DC, Teixeira MJ, de Andrade LA, Barsottini OG, Shih MC, Bressan RA, Ferraz HB.
    Med Sci Monit; 2014 Aug 11; 20():1413-8. PubMed ID: 25109468
    [Abstract] [Full Text] [Related]

  • 13. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E, Pedroso JL, Felicio AC, de Andrade DC, Teixeira MJ, Braga-Neto P, Batista IR, Barsottini OG, Borges V, Ferraz HB, Shih MC, Bressan RA, de Andrade LA, Walter U.
    Parkinsonism Relat Disord; 2014 May 11; 20(5):477-81. PubMed ID: 24629800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Sierra M, Martínez-Rodríguez I, Sánchez-Juan P, González-Aramburu I, Jiménez-Alonso M, Sánchez-Rodríguez A, Berciano J, Banzo I, Infante J.
    Neurology; 2017 Aug 01; 89(5):439-444. PubMed ID: 28679601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
    Berendse HW, Roos DS, Raijmakers P, Doty RL.
    J Neurol Sci; 2011 Nov 15; 310(1-2):21-4. PubMed ID: 21705022
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.